DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION was reported 797 times

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOROIDAL HAEMANGIOMA 1 0.1250
1 ANTERIOR SEGMENT NEOVASCULARISATION 1 0.0833
2 IRIS CYST 1 0.0455
3 AQUEOUS FIBRIN 1 0.0196
4 GLAUCOMA DRAINAGE DEVICE PLACEMENT 1 0.0172
5 RETINOPATHY HAEMORRHAGIC 1 0.0152
6 INFECTIVE SCLERITIS 1 0.0111
7 EYE OPACITY 1 0.0109
8 THERMAL BURNS OF EYE 2 0.0088
9 INTRAOCULAR PRESSURE TEST 2 0.0083
10 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 3 0.0083
11 NECROTISING SCLERITIS 1 0.0069
12 ABSCESS SOFT TISSUE 1 0.0065
13 EYE PARAESTHESIA 1 0.0064
14 INTRAOCULAR PRESSURE TEST ABNORMAL 4 0.0057
15 CHOROIDAL HAEMORRHAGE 1 0.0052
16 SCHWANNOMA 1 0.0050
17 TREATMENT FAILURE 416 0.0050
18 EYE EXCISION 1 0.0049
19 PRODUCT WITH QUALITY ISSUE ADMINISTERED 2 0.0045
20 PERIORBITAL INFLAMMATION 1 0.0043
21 VAGUS NERVE DISORDER 1 0.0040
22 CHEMICAL BURNS OF EYE 1 0.0036
23 OCULAR SURFACE DISEASE 1 0.0036
24 PERIORBITAL PAIN 3 0.0035
25 EYE ULCER 2 0.0035
26 PUNCTATE KERATITIS 3 0.0033
27 PRODUCT CONTAINER ISSUE 28 0.0033
28 HAEMORRHAGIC EROSIVE GASTRITIS 1 0.0031
29 ILEOSTOMY CLOSURE 1 0.0030
30 CORNEAL DEPOSITS 2 0.0027
31 CHOROIDAL EFFUSION 2 0.0025
32 PRODUCT SUBSTITUTION 1 0.0025
33 ACOUSTIC NEUROMA 1 0.0024
34 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
35 EXTRAOCULAR MUSCLE PARESIS 1 0.0022
36 LACRIMATION DECREASED 1 0.0021
37 PRODUCT AFTER TASTE 2 0.0021
38 ARTERIOVENOUS FISTULA 1 0.0020
39 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 1 0.0020
40 HYPHAEMA 1 0.0019
41 INTRAOCULAR PRESSURE DECREASED 1 0.0019
42 INSTILLATION SITE ERYTHEMA 1 0.0019
43 PERIORBITAL CELLULITIS 1 0.0019
44 CHOROIDAL DETACHMENT 1 0.0018
45 VISUAL ACUITY TESTS ABNORMAL 1 0.0018
46 CORNEAL EPITHELIUM DEFECT 1 0.0017
47 INSTILLATION SITE IRRITATION 2 0.0017
48 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
49 VITRECTOMY 1 0.0017
50 OPEN ANGLE GLAUCOMA 1 0.0016
51 CORNEAL PERFORATION 1 0.0016
52 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
53 EYELID PAIN 3 0.0015
54 RETINAL VEIN THROMBOSIS 1 0.0014
55 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
56 RADIOISOTOPE SCAN ABNORMAL 1 0.0014
57 ANTERIOR CHAMBER CELL 1 0.0014
58 CERVIX DISORDER 1 0.0014
59 BITE 1 0.0014
60 EYELID MARGIN CRUSTING 4 0.0014
61 CLONIC CONVULSION 1 0.0014
62 CORNEAL TRANSPLANT 1 0.0013
63 SKIN NEOPLASM EXCISION 1 0.0013
64 GROWTH OF EYELASHES 1 0.0013
65 HYPOPYON 1 0.0012
66 SEROUS RETINAL DETACHMENT 1 0.0012
67 INTRAOCULAR PRESSURE INCREASED 15 0.0012
68 ABSCESS DRAINAGE 1 0.0012
69 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
70 VASCULAR DEMENTIA 1 0.0011
71 ANAEMIA OF CHRONIC DISEASE 1 0.0011
72 PRODUCT STORAGE ISSUE 4 0.0011
73 EYELID RASH 1 0.0010
74 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
75 INNER EAR DISORDER 1 0.0009
76 INSTILLATION SITE REACTION 1 0.0009
77 TOXIC ANTERIOR SEGMENT SYNDROME 1 0.0009
78 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
79 CORNEAL OEDEMA 2 0.0009
80 INFECTION REACTIVATION 1 0.0009
81 ADMINISTRATION SITE PAIN 1 0.0009
82 MACROCYTOSIS 1 0.0009
83 EJECTION FRACTION ABNORMAL 1 0.0008
84 BLADDER DISCOMFORT 1 0.0008
85 NASAL PRURITUS 1 0.0008
86 EYELID IRRITATION 2 0.0008
87 SWELLING OF EYELID 5 0.0008
88 FOREIGN BODY SENSATION IN EYES 5 0.0008
89 RETINAL DEGENERATION 1 0.0008
90 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
91 HERPES OPHTHALMIC 1 0.0008
92 POSTPARTUM HAEMORRHAGE 1 0.0007
93 CORNEAL OPACITY 1 0.0007
94 INTESTINAL MASS 1 0.0007
95 ASTHENOPIA 4 0.0007
96 THERAPEUTIC PROCEDURE 1 0.0007
97 CHORIORETINOPATHY 1 0.0007
98 NAIL INFECTION 1 0.0007
99 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
100 EYE IRRITATION 39 0.0007
101 APRAXIA 1 0.0007
102 IMPETIGO 1 0.0007
103 PRODUCT DEPOSIT 1 0.0006
104 KERATOPATHY 1 0.0006
105 ILLUSION 1 0.0006
106 EYE PAIN 34 0.0006
107 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
108 ACUTE SINUSITIS 1 0.0006
109 EYE DISCHARGE 6 0.0006
110 CONJUNCTIVAL HYPERAEMIA 2 0.0006
111 PRODUCT TAMPERING 1 0.0006
112 PRODUCT RESIDUE PRESENT 3 0.0006
113 ERYTHEMA OF EYELID 3 0.0006
114 BLINDNESS TRANSIENT 4 0.0005
115 VITRITIS 1 0.0005
116 BLOOD CHOLESTEROL DECREASED 1 0.0005
117 GINGIVAL RECESSION 1 0.0005
118 SCIATICA 8 0.0005
119 PHOTOPHOBIA 9 0.0005
120 REACTION TO DRUG EXCIPIENTS 1 0.0005
121 CORNEAL DISORDER 1 0.0005
122 COLONOSCOPY 1 0.0005
123 PRODUCT LOT NUMBER ISSUE 1 0.0005
124 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
125 RENAL COLIC 1 0.0004
126 WRONG DOSE 1 0.0004
127 HYPERPARATHYROIDISM SECONDARY 1 0.0004
128 RETINAL DISORDER 1 0.0004
129 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
130 HAND DEFORMITY 5 0.0004
131 BLOOD POTASSIUM ABNORMAL 1 0.0004
132 PRODUCT DELIVERY MECHANISM ISSUE 2 0.0004
133 WEIGHT BEARING DIFFICULTY 1 0.0004
134 LARGE INTESTINAL ULCER 1 0.0004
135 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
136 OCULAR HYPERAEMIA 17 0.0004
137 MACULAR OEDEMA 2 0.0004
138 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
139 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
140 EYE INJURY 1 0.0003
141 FIBROSIS 1 0.0003
142 DEFORMITY 3 0.0003
143 EYELIDS PRURITUS 1 0.0003
144 BLOOD BLISTER 1 0.0003
145 PRODUCT USE COMPLAINT 5 0.0003
146 NON-CARDIAC CHEST PAIN 1 0.0003
147 GLAUCOMA 6 0.0003
148 PRODUCT FORMULATION ISSUE 2 0.0003
149 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
150 LEFT VENTRICULAR FAILURE 1 0.0003
151 CAROTID ARTERY OCCLUSION 1 0.0003
152 OCULAR DISCOMFORT 3 0.0003
153 CHRONIC SINUSITIS 1 0.0003
154 RESPIRATORY ACIDOSIS 1 0.0003
155 PNEUMONIA FUNGAL 1 0.0003
156 BLEPHARITIS 1 0.0002
157 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
158 EYE SWELLING 9 0.0002
159 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
160 PRODUCT DISPENSING ISSUE 1 0.0002
161 VISION BLURRED 32 0.0002
162 BLOOD MAGNESIUM DECREASED 2 0.0002
163 HORDEOLUM 1 0.0002
164 HAEMORRHAGIC ANAEMIA 1 0.0002
165 HYPERSENSITIVITY 42 0.0002
166 OROPHARYNGEAL DISCOMFORT 2 0.0002
167 PRODUCT DISTRIBUTION ISSUE 2 0.0002
168 PERFORMANCE STATUS DECREASED 1 0.0002
169 EYE INFLAMMATION 2 0.0002
170 EYE PRURITUS 7 0.0002
171 HORMONE LEVEL ABNORMAL 1 0.0002
172 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
173 HYPERVOLAEMIA 1 0.0002
174 LACRIMATION INCREASED 6 0.0002
175 EYELID PTOSIS 2 0.0002
176 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
177 FAILURE TO THRIVE 1 0.0002
178 FOOD CRAVING 1 0.0002
179 PRODUCT SIZE ISSUE 1 0.0002
180 FAECALOMA 1 0.0002
181 EYE INFECTION 2 0.0002
182 PERIORBITAL SWELLING 1 0.0002
183 PRODUCT AVAILABILITY ISSUE 4 0.0002
184 PRODUCT DOSE OMISSION ISSUE 50 0.0002
185 HEAD DISCOMFORT 3 0.0002
186 THIRST 3 0.0002
187 GANGRENE 1 0.0002
188 CONJUNCTIVITIS 3 0.0002
189 PRE-EXISTING CONDITION IMPROVED 1 0.0002
190 INFUSION SITE SWELLING 1 0.0002
191 SCREAMING 1 0.0002
192 APPETITE DISORDER 1 0.0002
193 EYE HAEMORRHAGE 2 0.0001
194 PRODUCT ADMINISTRATION ERROR 3 0.0001
195 UVEITIS 2 0.0001
196 PRODUCT LABEL ISSUE 1 0.0001
197 RESPIRATION ABNORMAL 1 0.0001
198 LARGE INTESTINE POLYP 1 0.0001
199 RETINAL HAEMORRHAGE 1 0.0001
200 FAECES SOFT 1 0.0001
201 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
202 MOUTH HAEMORRHAGE 1 0.0001
203 HYPOPHOSPHATAEMIA 1 0.0001
204 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
205 NO ADVERSE EVENT 24 0.0001
206 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
207 CONCUSSION 1 0.0001
208 THERAPY PARTIAL RESPONDER 2 0.0001
209 HAEMORRHAGIC STROKE 1 0.0001
210 GASTROINTESTINAL INFLAMMATION 1 0.0001
211 AFFECTIVE DISORDER 1 0.0001
212 TRICUSPID VALVE INCOMPETENCE 1 0.0001
213 ATRIAL FLUTTER 1 0.0001
214 TRANSPLANT REJECTION 1 0.0001
215 DECUBITUS ULCER 1 0.0001
216 HYPERAESTHESIA 1 0.0001
217 EYE DISORDER 4 0.0001
218 PHOTOSENSITIVITY REACTION 2 0.0001
219 LIVE BIRTH 1 0.0001
220 INFUSION SITE ERYTHEMA 1 0.0001
221 PSEUDOMONAS INFECTION 1 0.0001
222 PSYCHOLOGICAL TRAUMA 1 0.0001
223 URINE OUTPUT DECREASED 1 0.0001
224 BURNING SENSATION 8 0.0001
225 HEART RATE DECREASED 4 0.0001
226 VISUAL IMPAIRMENT 14 0.0001
227 GALLBLADDER DISORDER 2 0.0001
228 ANAL INCONTINENCE 1 0.0001
229 END STAGE RENAL DISEASE 2 0.0001
230 UROSEPSIS 1 0.0001
231 PERSONALITY CHANGE 1 0.0001
232 ERYTHEMA MULTIFORME 1 0.0001
233 FLANK PAIN 1 0.0001
234 PRODUCT PACKAGING ISSUE 1 0.0001
235 RECALLED PRODUCT ADMINISTERED 1 0.0001
236 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
237 PRODUCT QUALITY ISSUE 14 0.0001
238 AUTOIMMUNE DISORDER 1 0.0001
239 FULL BLOOD COUNT DECREASED 2 0.0001
240 SUBARACHNOID HAEMORRHAGE 1 0.0001
241 SLUGGISHNESS 1 0.0001
242 EAR DISCOMFORT 1 0.0001
243 VENTRICULAR EXTRASYSTOLES 1 0.0001
244 TRANSFUSION 1 0.0001
245 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
246 SCRATCH 1 0.0001
247 RENAL PAIN 1 0.0001
248 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
249 BREAST PAIN 1 0.0001
250 BODY HEIGHT DECREASED 1 0.0001
251 BIPOLAR DISORDER 1 0.0001
252 PRODUCT DISPENSING ERROR 2 0.0001
253 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
254 OESOPHAGITIS 1 0.0001
255 DENTAL CARIES 1 0.0001
256 VISUAL ACUITY REDUCED 3 0.0001
257 INTESTINAL PERFORATION 1 0.0001
258 BLOOD CALCIUM DECREASED 1 0.0001
259 SCAB 1 0.0001
260 MICTURITION URGENCY 1 0.0001
261 NEOPLASM 1 0.0001
262 ELECTROLYTE IMBALANCE 1 0.0001
263 EYELID OEDEMA 1 0.0001
264 VASCULITIS 1 0.0001
265 SPLENOMEGALY 1 0.0001
266 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
267 NOCTURIA 1 0.0001
268 ACCIDENTAL OVERDOSE 3 0.0001
269 CARDIOMEGALY 1 0.0001
270 GENERALISED OEDEMA 1 0.0001
271 ILEUS 1 0.0001
272 SECRETION DISCHARGE 1 0.0001
273 DERMATITIS ALLERGIC 1 0.0001
274 AKATHISIA 1 0.0001
275 ACUTE HEPATIC FAILURE 1 0.0001
276 TREATMENT NONCOMPLIANCE 4 0.0001
277 INJECTION SITE REACTION 5 0.0001
278 ATRIAL FIBRILLATION 7 0.0001
279 HYPOMAGNESAEMIA 1 0.0001
280 WOUND 2 0.0001
281 BLINDNESS UNILATERAL 1 0.0001
282 SEASONAL ALLERGY 1 0.0001
283 PARALYSIS 1 0.0001
284 SUBDURAL HAEMATOMA 1 0.0001
285 HYPERSOMNIA 2 0.0001
286 APATHY 1 0.0001
287 PRODUCT STORAGE ERROR 6 0.0001
288 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
289 CARDIOMYOPATHY 1 0.0001
290 CATARACT 4 0.0001
291 THERAPY NON-RESPONDER 3 0.0001
292 APHASIA 2 0.0001
293 SKIN IRRITATION 3 0.0001
294 INSURANCE ISSUE 1 0.0001
295 ANKLE FRACTURE 1 0.0001
296 ABSCESS 1 0.0001
297 HYPOGLYCAEMIA 3 0.0001
298 MUSCLE TIGHTNESS 1 0.0001
299 DRY EYE 3 0.0001
300 COAGULOPATHY 1 0.0001
301 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
302 DEVICE USE ISSUE 1 0.0001
303 BRADYCARDIA 3 0.0001
304 GOUT 1 0.0001
305 MOBILITY DECREASED 4 0.0001
306 OEDEMA 3 0.0001
307 DRUG EFFECT INCOMPLETE 2 0.0001
308 DYSURIA 2 0.0001
309 BLOOD GLUCOSE ABNORMAL 1 0.0001
310 HEPATIC STEATOSIS 1 0.0001
311 HYPONATRAEMIA 3 0.0001
312 INTESTINAL OBSTRUCTION 2 0.0001
313 BLOOD SODIUM DECREASED 1 0.0001
314 HYPOCALCAEMIA 1 0.0001
315 SLEEP APNOEA SYNDROME 1 0.0001
316 ACUTE RESPIRATORY FAILURE 1 0.0001
317 DRUG INTOLERANCE 5 0.0001
318 NASAL CONGESTION 3 0.0001
319 ARTHRITIS 4 0.0001
320 CYTOKINE RELEASE SYNDROME 1 0.0000
321 PRODUCT PHYSICAL ISSUE 1 0.0000
322 EXTRA DOSE ADMINISTERED 2 0.0000
323 CONDITION AGGRAVATED 15 0.0000
324 TASTE DISORDER 1 0.0000
325 BLINDNESS 2 0.0000
326 BODY TEMPERATURE INCREASED 1 0.0000
327 POLLAKIURIA 2 0.0000
328 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
329 MOUTH ULCERATION 1 0.0000
330 RETCHING 1 0.0000
331 SKIN CANCER 1 0.0000
332 PRURITUS GENERALISED 1 0.0000
333 FAECES DISCOLOURED 1 0.0000
334 MELAENA 1 0.0000
335 RASH MACULO-PAPULAR 1 0.0000
336 HEART RATE IRREGULAR 1 0.0000
337 RHEUMATOID ARTHRITIS 5 0.0000
338 NEPHROLITHIASIS 2 0.0000
339 TINNITUS 2 0.0000
340 HYPOKALAEMIA 2 0.0000
341 PRODUCT PRESCRIBING ERROR 1 0.0000
342 BLOOD PRESSURE FLUCTUATION 1 0.0000
343 DIABETIC KETOACIDOSIS 1 0.0000
344 RESPIRATORY FAILURE 3 0.0000
345 DYSGEUSIA 3 0.0000
346 HALLUCINATION 3 0.0000
347 PRODUCT COMPLAINT 1 0.0000
348 HAEMATEMESIS 1 0.0000
349 CARDIOVASCULAR DISORDER 1 0.0000
350 BLOOD PRESSURE INCREASED 6 0.0000
351 HYPOPHAGIA 1 0.0000
352 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
353 SKIN ULCER 1 0.0000
354 EXPOSURE VIA SKIN CONTACT 1 0.0000
355 RESPIRATORY TRACT INFECTION 1 0.0000
356 DEAFNESS 1 0.0000
357 ECZEMA 2 0.0000
358 SEDATION 1 0.0000
359 JOINT STIFFNESS 1 0.0000
360 DEPRESSED MOOD 2 0.0000
361 FREQUENT BOWEL MOVEMENTS 1 0.0000
362 PALLOR 1 0.0000
363 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
364 DIVERTICULITIS 1 0.0000
365 PROCEDURAL PAIN 1 0.0000
366 MUSCULAR WEAKNESS 4 0.0000
367 RED BLOOD CELL COUNT DECREASED 1 0.0000
368 PRODUCT SUBSTITUTION ISSUE 2 0.0000
369 BALANCE DISORDER 3 0.0000
370 BLOOD POTASSIUM DECREASED 1 0.0000
371 LIMB DISCOMFORT 1 0.0000
372 DRUG-INDUCED LIVER INJURY 1 0.0000
373 MIGRAINE 3 0.0000
374 GAIT DISTURBANCE 6 0.0000
375 METABOLIC ACIDOSIS 1 0.0000
376 HIP FRACTURE 1 0.0000
377 HYPERHIDROSIS 4 0.0000
378 AMNESIA 2 0.0000
379 DECREASED APPETITE 7 0.0000
380 GAIT INABILITY 1 0.0000
381 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
382 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
383 MYALGIA 5 0.0000
384 ERYTHEMA 6 0.0000
385 NEOPLASM PROGRESSION 1 0.0000
386 WEIGHT DECREASED 8 0.0000
387 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
388 PLATELET COUNT DECREASED 3 0.0000
389 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
390 PRODUCT ADHESION ISSUE 1 0.0000
391 SKIN BURNING SENSATION 2 0.0000
392 HYPERGLYCAEMIA 1 0.0000
393 PANIC ATTACK 1 0.0000
394 RESTLESSNESS 1 0.0000
395 DRUG INEFFECTIVE 36 0.0000
396 EPISTAXIS 2 0.0000
397 PRODUCT USE ISSUE 5 0.0000
398 UNEVALUABLE EVENT 2 0.0000
399 COLITIS 1 0.0000
400 CHRONIC KIDNEY DISEASE 2 0.0000
401 DIABETES MELLITUS 2 0.0000
402 ALOPECIA 5 0.0000
403 DISORIENTATION 1 0.0000
404 CARDIAC FAILURE 2 0.0000
405 SOMNOLENCE 5 0.0000
406 PNEUMONIA 8 0.0000
407 OEDEMA PERIPHERAL 3 0.0000
408 TREMOR 4 0.0000
409 DIZZINESS 12 0.0000
410 RHABDOMYOLYSIS 1 0.0000
411 ROAD TRAFFIC ACCIDENT 1 0.0000
412 OSTEOARTHRITIS 1 0.0000
413 HYPOACUSIS 1 0.0000
414 SEPTIC SHOCK 1 0.0000
415 DYSPNOEA 13 0.0000
416 COVID-19 4 0.0000
417 PAIN 14 0.0000
418 ANGIOEDEMA 1 0.0000
419 DRY SKIN 3 0.0000
420 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
421 PULMONARY OEDEMA 1 0.0000
422 WEIGHT INCREASED 5 0.0000
423 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
424 THROAT IRRITATION 1 0.0000
425 MUSCLE SPASMS 4 0.0000
426 SWELLING 2 0.0000
427 FALL 7 0.0000
428 RASH ERYTHEMATOUS 1 0.0000
429 BLOOD GLUCOSE DECREASED 1 0.0000
430 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
431 PRURITUS 8 0.0000
432 CONTUSION 2 0.0000
433 DYSPEPSIA 2 0.0000
434 HEART RATE INCREASED 2 0.0000
435 LEUKOPENIA 1 0.0000
436 HYPOTENSION 4 0.0000
437 CELLULITIS 1 0.0000
438 CHEST DISCOMFORT 2 0.0000
439 HOSPITALISATION 3 0.0000
440 PERIPHERAL SWELLING 3 0.0000
441 ILLNESS 2 0.0000
442 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
443 INFLAMMATION 1 0.0000
444 HEADACHE 12 0.0000
445 SPEECH DISORDER 1 0.0000
446 PARAESTHESIA 3 0.0000
447 DIARRHOEA 12 0.0000
448 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
449 HAEMATOCHEZIA 1 0.0000
450 FATIGUE 14 0.0000
451 URTICARIA 3 0.0000
452 NECK PAIN 1 0.0000
453 PANCYTOPENIA 1 0.0000
454 THROMBOCYTOPENIA 2 0.0000
455 ASTHMA 2 0.0000
456 FLATULENCE 1 0.0000
457 URINARY TRACT INFECTION 3 0.0000
458 SEIZURE 2 0.0000
459 BONE PAIN 1 0.0000
460 CHILLS 2 0.0000
461 SURGERY 1 0.0000
462 WHEEZING 1 0.0000
463 EMOTIONAL DISTRESS 2 0.0000
464 THERAPEUTIC RESPONSE DECREASED 1 0.0000
465 STOMATITIS 1 0.0000
466 PLEURAL EFFUSION 1 0.0000
467 VERTIGO 1 0.0000
468 DISCOMFORT 1 0.0000
469 FEELING HOT 1 0.0000
470 NASOPHARYNGITIS 3 0.0000
471 RASH 7 0.0000
472 ASTHENIA 6 0.0000
473 BLOOD GLUCOSE INCREASED 3 0.0000
474 LOSS OF CONSCIOUSNESS 2 0.0000
475 RHINORRHOEA 1 0.0000
476 PRODUCT DOSE OMISSION 1 0.0000
477 INFUSION RELATED REACTION 1 0.0000
478 FEBRILE NEUTROPENIA 1 0.0000
479 INSOMNIA 4 0.0000
480 OFF LABEL USE 13 0.0000
481 SLEEP DISORDER 1 0.0000
482 THERAPY INTERRUPTED 1 0.0000
483 CONSTIPATION 3 0.0000
484 UNDERDOSE 1 0.0000
485 HYPOAESTHESIA 2 0.0000
486 INCORRECT DOSE ADMINISTERED 3 0.0000
487 ACUTE KIDNEY INJURY 2 0.0000
488 ABDOMINAL PAIN 3 0.0000
489 NAUSEA 10 0.0000
490 DRUG INTERACTION 2 0.0000
491 CARDIAC FAILURE CONGESTIVE 1 0.0000
492 THROMBOSIS 1 0.0000
493 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
494 CONFUSIONAL STATE 2 0.0000
495 CARDIAC ARREST 1 0.0000
496 ABDOMINAL DISCOMFORT 2 0.0000
497 RENAL IMPAIRMENT 1 0.0000
498 SKIN EXFOLIATION 1 0.0000
499 INTENTIONAL PRODUCT MISUSE 1 0.0000
500 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
501 MUSCULOSKELETAL STIFFNESS 1 0.0000
502 TACHYCARDIA 1 0.0000
503 DEVICE ISSUE 1 0.0000
504 ADVERSE DRUG REACTION 1 0.0000
505 SUICIDAL IDEATION 1 0.0000
506 OROPHARYNGEAL PAIN 1 0.0000
507 CHEST PAIN 2 0.0000
508 COUGH 3 0.0000
509 CARDIAC DISORDER 1 0.0000
510 VOMITING 5 0.0000
511 ANAEMIA 2 0.0000
512 FLUSHING 1 0.0000
513 ABDOMINAL PAIN UPPER 2 0.0000
514 SEPSIS 1 0.0000
515 PYREXIA 3 0.0000
516 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
517 BACK PAIN 2 0.0000
518 PALPITATIONS 1 0.0000
519 DISEASE PROGRESSION 1 0.0000
520 FEELING ABNORMAL 2 0.0000
521 RENAL FAILURE 1 0.0000
522 NEUTROPENIA 1 0.0000
523 ARTHRALGIA 3 0.0000
524 ANXIETY 2 0.0000
525 DEATH 6 0.0000
526 INFECTION 1 0.0000
527 PAIN IN EXTREMITY 2 0.0000
528 CEREBROVASCULAR ACCIDENT 1 0.0000
529 MYOCARDIAL INFARCTION 1 0.0000
530 OVERDOSE 1 0.0000
531 MALAISE 2 0.0000
532 DEPRESSION 1 0.0000
533 INJECTION SITE PAIN 1 0.0000